Assessing the in vivo targeting efficiency of multifunctional nanoconstructs bearing antibody-derived ligands

Luisa Fiandra, Serena Mazzucchelli, Clara De Palma, Miriam Colombo, Raffaele Allevi, Silvia Sommaruga, Emilio Clementi, Michela Bellini, Davide Prosperi, Fabio Corsi

Research output: Contribution to journalArticle

Abstract

A great challenge in nanodiagnostics is the identification of new strategies aimed to optimize the detection of primary breast cancer and metastases by the employment of target-specific nanodevices. At present, controversial proof has been provided on the actual importance of surface functionalization of nanoparticles to improve their in vivo localization at the tumor. In the present paper, we have designed and developed a set of multifunctional nanoprobes, modified with three different variants of a model antibody, that is, the humanized monocolonal antibody trastuzumab (TZ), able to selectively target the HER2 receptor in breast cancer cells. Assuming that nanoparticle accumulation in target cells is strictly related to their physicochemical properties, we performed a comparative study of internalization, trafficking, and metabolism in MCF7 cells of multifunctional nanoparticles (MNP) functionalized with TZ or with alternative lower molecular weight variants of the monoclonal antibody, such as the half-chain (HC) and scFv fragments (scFv). Hence, to estimate to what extent the structure of the surface bioligand affects the targeting efficiency of the nanoconjugate, three cognate nanoconstructs were designed, in which only the antibody form was differentiated while the nanoparticle core was maintained unvaried, consisting of an iron oxide spherical nanocrystal coated with an amphiphilic polymer shell. In vitro, in vivo, and ex vivo analyses of the targeting efficiency and of the intracellular fate of MNP-TZ, MNP-HC, and MNP-scFv suggested that the highly stable MNP-HC is the best candidate for application in breast cancer detection. Our results provided evidence that, in this case, active targeting plays an important role in determining the biological activity of the nanoconstruct.

Original languageEnglish
Pages (from-to)6092-6102
Number of pages11
JournalACS Nano
Volume7
Issue number7
DOIs
Publication statusPublished - Jul 23 2013

Fingerprint

Bearings (structural)
antibodies
Antibodies
Nanoparticles
Ligands
nanoparticles
ligands
breast
cancer
Breast Neoplasms
Nanoconjugates
Nanoprobes
Antibodies, Monoclonal, Humanized
Monoclonal antibodies
metastasis
metabolism
low molecular weights
activity (biology)
Bioactivity
cells

Keywords

  • active targeting
  • breast cancer detection
  • intracellular trafficking
  • ligand-receptor recognition
  • magnetic nanoparticles

ASJC Scopus subject areas

  • Engineering(all)
  • Materials Science(all)
  • Physics and Astronomy(all)
  • Medicine(all)

Cite this

Fiandra, L., Mazzucchelli, S., De Palma, C., Colombo, M., Allevi, R., Sommaruga, S., ... Corsi, F. (2013). Assessing the in vivo targeting efficiency of multifunctional nanoconstructs bearing antibody-derived ligands. ACS Nano, 7(7), 6092-6102. https://doi.org/10.1021/nn4018922

Assessing the in vivo targeting efficiency of multifunctional nanoconstructs bearing antibody-derived ligands. / Fiandra, Luisa; Mazzucchelli, Serena; De Palma, Clara; Colombo, Miriam; Allevi, Raffaele; Sommaruga, Silvia; Clementi, Emilio; Bellini, Michela; Prosperi, Davide; Corsi, Fabio.

In: ACS Nano, Vol. 7, No. 7, 23.07.2013, p. 6092-6102.

Research output: Contribution to journalArticle

Fiandra, L, Mazzucchelli, S, De Palma, C, Colombo, M, Allevi, R, Sommaruga, S, Clementi, E, Bellini, M, Prosperi, D & Corsi, F 2013, 'Assessing the in vivo targeting efficiency of multifunctional nanoconstructs bearing antibody-derived ligands', ACS Nano, vol. 7, no. 7, pp. 6092-6102. https://doi.org/10.1021/nn4018922
Fiandra L, Mazzucchelli S, De Palma C, Colombo M, Allevi R, Sommaruga S et al. Assessing the in vivo targeting efficiency of multifunctional nanoconstructs bearing antibody-derived ligands. ACS Nano. 2013 Jul 23;7(7):6092-6102. https://doi.org/10.1021/nn4018922
Fiandra, Luisa ; Mazzucchelli, Serena ; De Palma, Clara ; Colombo, Miriam ; Allevi, Raffaele ; Sommaruga, Silvia ; Clementi, Emilio ; Bellini, Michela ; Prosperi, Davide ; Corsi, Fabio. / Assessing the in vivo targeting efficiency of multifunctional nanoconstructs bearing antibody-derived ligands. In: ACS Nano. 2013 ; Vol. 7, No. 7. pp. 6092-6102.
@article{cbf65cd0d0d3434faadb0c29437ad3e2,
title = "Assessing the in vivo targeting efficiency of multifunctional nanoconstructs bearing antibody-derived ligands",
abstract = "A great challenge in nanodiagnostics is the identification of new strategies aimed to optimize the detection of primary breast cancer and metastases by the employment of target-specific nanodevices. At present, controversial proof has been provided on the actual importance of surface functionalization of nanoparticles to improve their in vivo localization at the tumor. In the present paper, we have designed and developed a set of multifunctional nanoprobes, modified with three different variants of a model antibody, that is, the humanized monocolonal antibody trastuzumab (TZ), able to selectively target the HER2 receptor in breast cancer cells. Assuming that nanoparticle accumulation in target cells is strictly related to their physicochemical properties, we performed a comparative study of internalization, trafficking, and metabolism in MCF7 cells of multifunctional nanoparticles (MNP) functionalized with TZ or with alternative lower molecular weight variants of the monoclonal antibody, such as the half-chain (HC) and scFv fragments (scFv). Hence, to estimate to what extent the structure of the surface bioligand affects the targeting efficiency of the nanoconjugate, three cognate nanoconstructs were designed, in which only the antibody form was differentiated while the nanoparticle core was maintained unvaried, consisting of an iron oxide spherical nanocrystal coated with an amphiphilic polymer shell. In vitro, in vivo, and ex vivo analyses of the targeting efficiency and of the intracellular fate of MNP-TZ, MNP-HC, and MNP-scFv suggested that the highly stable MNP-HC is the best candidate for application in breast cancer detection. Our results provided evidence that, in this case, active targeting plays an important role in determining the biological activity of the nanoconstruct.",
keywords = "active targeting, breast cancer detection, intracellular trafficking, ligand-receptor recognition, magnetic nanoparticles",
author = "Luisa Fiandra and Serena Mazzucchelli and {De Palma}, Clara and Miriam Colombo and Raffaele Allevi and Silvia Sommaruga and Emilio Clementi and Michela Bellini and Davide Prosperi and Fabio Corsi",
year = "2013",
month = "7",
day = "23",
doi = "10.1021/nn4018922",
language = "English",
volume = "7",
pages = "6092--6102",
journal = "ACS Nano",
issn = "1936-0851",
publisher = "American Chemical Society",
number = "7",

}

TY - JOUR

T1 - Assessing the in vivo targeting efficiency of multifunctional nanoconstructs bearing antibody-derived ligands

AU - Fiandra, Luisa

AU - Mazzucchelli, Serena

AU - De Palma, Clara

AU - Colombo, Miriam

AU - Allevi, Raffaele

AU - Sommaruga, Silvia

AU - Clementi, Emilio

AU - Bellini, Michela

AU - Prosperi, Davide

AU - Corsi, Fabio

PY - 2013/7/23

Y1 - 2013/7/23

N2 - A great challenge in nanodiagnostics is the identification of new strategies aimed to optimize the detection of primary breast cancer and metastases by the employment of target-specific nanodevices. At present, controversial proof has been provided on the actual importance of surface functionalization of nanoparticles to improve their in vivo localization at the tumor. In the present paper, we have designed and developed a set of multifunctional nanoprobes, modified with three different variants of a model antibody, that is, the humanized monocolonal antibody trastuzumab (TZ), able to selectively target the HER2 receptor in breast cancer cells. Assuming that nanoparticle accumulation in target cells is strictly related to their physicochemical properties, we performed a comparative study of internalization, trafficking, and metabolism in MCF7 cells of multifunctional nanoparticles (MNP) functionalized with TZ or with alternative lower molecular weight variants of the monoclonal antibody, such as the half-chain (HC) and scFv fragments (scFv). Hence, to estimate to what extent the structure of the surface bioligand affects the targeting efficiency of the nanoconjugate, three cognate nanoconstructs were designed, in which only the antibody form was differentiated while the nanoparticle core was maintained unvaried, consisting of an iron oxide spherical nanocrystal coated with an amphiphilic polymer shell. In vitro, in vivo, and ex vivo analyses of the targeting efficiency and of the intracellular fate of MNP-TZ, MNP-HC, and MNP-scFv suggested that the highly stable MNP-HC is the best candidate for application in breast cancer detection. Our results provided evidence that, in this case, active targeting plays an important role in determining the biological activity of the nanoconstruct.

AB - A great challenge in nanodiagnostics is the identification of new strategies aimed to optimize the detection of primary breast cancer and metastases by the employment of target-specific nanodevices. At present, controversial proof has been provided on the actual importance of surface functionalization of nanoparticles to improve their in vivo localization at the tumor. In the present paper, we have designed and developed a set of multifunctional nanoprobes, modified with three different variants of a model antibody, that is, the humanized monocolonal antibody trastuzumab (TZ), able to selectively target the HER2 receptor in breast cancer cells. Assuming that nanoparticle accumulation in target cells is strictly related to their physicochemical properties, we performed a comparative study of internalization, trafficking, and metabolism in MCF7 cells of multifunctional nanoparticles (MNP) functionalized with TZ or with alternative lower molecular weight variants of the monoclonal antibody, such as the half-chain (HC) and scFv fragments (scFv). Hence, to estimate to what extent the structure of the surface bioligand affects the targeting efficiency of the nanoconjugate, three cognate nanoconstructs were designed, in which only the antibody form was differentiated while the nanoparticle core was maintained unvaried, consisting of an iron oxide spherical nanocrystal coated with an amphiphilic polymer shell. In vitro, in vivo, and ex vivo analyses of the targeting efficiency and of the intracellular fate of MNP-TZ, MNP-HC, and MNP-scFv suggested that the highly stable MNP-HC is the best candidate for application in breast cancer detection. Our results provided evidence that, in this case, active targeting plays an important role in determining the biological activity of the nanoconstruct.

KW - active targeting

KW - breast cancer detection

KW - intracellular trafficking

KW - ligand-receptor recognition

KW - magnetic nanoparticles

UR - http://www.scopus.com/inward/record.url?scp=84880844671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880844671&partnerID=8YFLogxK

U2 - 10.1021/nn4018922

DO - 10.1021/nn4018922

M3 - Article

C2 - 23758591

AN - SCOPUS:84880844671

VL - 7

SP - 6092

EP - 6102

JO - ACS Nano

JF - ACS Nano

SN - 1936-0851

IS - 7

ER -